Sphera Funds Management Ltd. Dyne Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

$380 Million
Q1 2025

A detailed history of Sphera Funds Management Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 329,262 shares of DYN stock, worth $2.96 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

329,262

Previous 236,262 39.36%

Holding current value

$2.96 Million

Previous $5.57 Million 38.12%

% of portfolio

0.91%

Previous 1.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$10.46 - $25.46 $972,780 - $2.37 Million	93,000 Added 39.36%	329,262 $3.44 Million
Q4 2024 Feb 14, 2025	BUY	$23.56 - $35.55 $4.24 Million - $6.39 Million	179,758 Added 318.13%	236,262 $5.57 Million
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $1.8 Million - $2.66 Million	56,504 New	56,504 $2.03 Million
Q2 2023 Aug 14, 2023	SELL	$8.53 - $14.28 $847,864 - $1.42 Million	-99,398 Reduced 45.32%	119,918 $1.35 Million
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $2.31 Million - $3.18 Million	212,167 Added 2967.79%	219,316 $2.53 Million
Q4 2022 Feb 14, 2023	BUY	$9.37 - $13.8 $66,986 - $98,656	7,149 New	7,149 $82,000
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $685,930 - $1.29 Million	-105,204 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.89 - $16.07 $1.43 Million - $1.93 Million	-119,879 Reduced 53.26%	105,204 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $2.26 Million - $3.1 Million	-144,631 Reduced 39.12%	225,083 $3.66 Million
Q2 2021 Aug 17, 2021	SELL	$15.94 - $22.33 $1.28 Million - $1.79 Million	-80,350 Reduced 17.85%	369,714 $7.78 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $4.9 Million - $10.3 Million	350,064 Added 350.06%	450,064 $6.99 Million
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $504,299 - $718,200	30,000 Added 42.86%	100,000 $2.1 Million
Q3 2020 Nov 12, 2020	BUY	$20.0 - $23.9 $1.4 Million - $1.67 Million	70,000 New	70,000 $1.41 Million

Others Institutions Holding DYN

# of Institutions

216

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $466M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Dyne Therapeutics, Inc. Transaction History